Yumanity Therapeutics (YMTX) executive Iadonato received 207,000 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Shawn Iadonato (executive at Yumanity Therapeutics Inc., YMTX) reported that they received 207,000 Stock Option (Right to Buy) on Apr 12, 2023.
- Reporting person
- Iadonato Shawn
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Apr 12, 2023 | Grant or award (A) | Stock Option (Right to Buy)On 207,000 Common Stock1 | +207,000 | - | - | 207,000 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 207,000 direct
Footnotes from the filing
- 1. The stock option vests as to 25% of the total number of shares upon grant, and an additional 1/36 of the remaining number of shares will vest on May 1, 2023 and each monthly anniversary thereafter, subject to the continuing employment of the Reporting Person on each vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Iadonato report in this YMTX Form 4?
Shawn Iadonato (executive at Yumanity Therapeutics Inc., YMTX) reported that they received 207,000 Stock Option (Right to Buy) on Apr 12, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for YMTX
Earlier insider filings at YMTX
- Apr 14, 2023SEC Form 4 filed by Guillaudeux Thierry
- Apr 14, 2023SEC Form 4 filed by Foote Marion R
- Apr 14, 2023SEC Form 4 filed by Bartoszek Raymond J.
- Apr 14, 2023SEC Form 4 filed by Baker Keith
- Apr 14, 2023SEC Form 4 filed by Arkowitz David
Keep researching YMTX
- YMTX insider tradesEvery buy and sale reported by Yumanity Therapeutics Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
YMTX
Yumanity Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Get push alerts for YMTX
Full YMTX profile on Quantisnow Follow YMTX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time